Brain health study for HIV+ stimulant users
Part of Immune system & allergy, Infections, Mental health clinical trials.
This study uses brain scans to understand how stimulant use affects the brain in people with HIV who are on treatment. It may help find ways to improve brain health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 59 years old.
- You use stimulants (like cocaine or methamphetamine) at least weekly, or have a high score on the ASSIST substance use test.
- You have HIV and take daily antiretroviral medication (ART).
- You are fluent in English and can read/write.
- You do not have any metal implants or other reasons that make MRI unsafe.
- If you take antidepressants, you must have been on the same dose for at least 2 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how depression and its treatment may affect the brain and immune-related body systems in people with HIV. You may be eligible if you have depression and a well-controlled HIV viral load, and you can safely complete brain MRI scans.
This study looks at brain activity to understand how depression and cannabis use may be linked in young adults living with HIV. It mainly involves questionnaires, mental health screening, and brain scans, which may help researchers better understand risk factors and brain “underpinnings.”
This study looks at whether ongoing marijuana use changes “brain inflammation” and brain cell injury in people living with HIV. It may help researchers understand potential risks or protective effects and how treatment and brain health interact.
This study tests a program that combines rewards for healthy choices with help managing emotions and urges, aimed at supporting people who use stimulants to stay healthy and consider HIV prevention.
This study uses PET and MRI scans, plus blood tests and memory/thinking questionnaires, to understand what drives brain problems in people living with HIV even during treatment. It may help researchers learn why symptoms happen and how treatment relates to brain function.
This study looks at how an HIV treatment and prevention program can be improved for people who have HIV plus psychosocial challenges, especially when HIV is not well controlled. You may be able to join if your HIV is recent and higher than target, and you fit one of the specific participant groups.
Hear when a new Stimulant Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.